Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide vs Insulin Glargine in T2DM (T-emerge 5)
NCT00755287Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2008
- Primary completion
- Dec 2010
- Modality
- Peptides
- Countries
- 27
01
Overview
A Phase 3 trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Nov 2008; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00755287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755287.